The Parkinson Alliance is committed to raising funds for the most promising and scientifically validated Parkinsons disease research that will help find the cure to Parkinsons. A primary focus of the Alliance is raising funds for pilot study programs that allow researchers to qualify for major funding from the National Institutes of Health (NIH) the primary funding source for research dollars in the U.S. Each year NIH establishes a set of funding plans based on the appropriations received from Congress. The Parkinson Alliance raises funds through donations and by conducting a variety of events across the country
Selection of a grant is on the basis of scientific merit of the project. This is determined by the Scientific Advisory Boards of the national organizations, which provide the expertise to judge the selection of research projects. Typical grants are awarded in the $35,000 - $50,000 range, sufficient to compile the pilot data that must accompany all NINDS grant applications.
We invite you to view the list of grants we have presented to fund Parkinsons disease research by clicking on the Funded Research links on the left.
In addition to the pilot study grants program, The Parkinson Alliance is proud to be taking part in an unprecedented collaboration with the NIH and private Parkinsons organizations to jointly fund a program of $11 million in Parkinsons disease research grants. Since 2001 the R21 Fast Track Grant Program awarded 35 two-year grants making it the largest initiative that NIH has ever undertaken in the history of Parkinsons disease research. The awards were made through an innovative streamlining of the NIHs normal grant process. The goal is to stimulate novel, or high impact approaches relevant to the cure, cause, prevention, or improved treatments of Parkinsons disease.
The Alliance is also participating in a two-year $4.4 million research initiative, started in 2001 and led by The Michael J. Fox Foundation for Parkinsons Research, to produce a cell line specifically designed to advance the study and treatment of Parkinsons disease. Once developed, the cell line will be made available to Parkinsons researchers worldwide.
The National Institute of Neurological Disorders and Stroke (NINDS) is the agency responsible for conducting and coordinating research on the causes, prevention, diagnosis, and treatment of neurological disorders and stroke, as well as supporting basic research in the related scientific areas.
If you are an investigator or researcher working in the field of neurological disorders, and you are interested in applying for pilot study grants to collect data in preparation for a NINDS grant, please visit our Where to Apply for a Grant page. To learn about the NINDS grant application process, please visit the NINDS page.